|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.340 USD | +0.86% |
|
+1.74% | +103.48% |
| Market Cap | 1.04B 903M 838M 773M 1.46B 99.23B 1.48B 9.93B 3.89B 49.28B 3.9B 3.82B 166B | P/E 2026 * |
-14.9x | P/E 2027 * | -12.3x |
|---|---|---|---|---|---|
| Enterprise Value | 1.04B 903M 838M 773M 1.46B 99.23B 1.48B 9.93B 3.89B 49.28B 3.9B 3.82B 166B | EV / Sales 2026 * |
27.2x | EV / Sales 2027 * | 51.6x |
| Free-Float |
98.45% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Lexicon Pharmaceuticals, Inc.
| 1 day | +0.86% | ||
| 1 week | +1.74% | ||
| Current month | -2.50% | ||
| 1 month | -2.50% | ||
| 3 months | +45.34% | ||
| 6 months | +101.72% | ||
| Current year | +103.48% |
| 1 week | 2.16 |  | 2.42 |
| 1 month | 2.04 | | 2.44 |
| Current year | 1.1 | | 2.68 |
| 1 year | 1.02 | | 2.68 |
| 3 years | 0.28 | | 3.73 |
| 5 years | 0.28 | | 6.33 |
| 10 years | 0.28 | | 19.62 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Exton
CEO | Chief Executive Officer | 56 | 08/07/2024 |
Scott Coiante
DFI | Director of Finance/CFO | 59 | 02/01/2025 |
Michael Davies
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Samuel Barker
CHM | Chairman | 83 | 01/01/2005 |
Ray Debbane
CHM | Chairman | 71 | 27/02/2012 |
| Director/Board Member | 67 | 28/08/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 28/02/26 | Fiscal year | General Counsel | 651,031 | 0.1792% | ||
| 28/02/26 | Fiscal year | Chief Executive Officer | 1,211,357 | 0.3333% | ||
| 28/02/26 | Fiscal year | Chief Financial Officer | 375,355 | 0.1033% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.86% | +1.74% | +129.41% | +18.18% | 1.04B | |
| -0.81% | -0.33% | +27.15% | +81.12% | 55.23B | |
| +2.17% | -5.17% | +28.33% | +66.91% | 53.75B | |
| -0.11% | +0.86% | -15.63% | -13.56% | 23.48B | |
| -1.58% | -5.51% | -3.51% | +375.36% | 22B | |
| +2.49% | -0.92% | +20.31% | -12.15% | 19.78B | |
| +0.18% | -1.73% | +28.42% | -33.76% | 17.44B | |
| +0.58% | -5.88% | +16.30% | +540.37% | 14.66B | |
| +1.16% | +0.58% | +51.87% | +181.96% | 14.07B | |
| -5.09% | -10.87% | +153.11% | +272.20% | 13.02B | |
| Average | -0.01% | -1.56% | +43.58% | +147.66% | 23.45B | |
| Weighted average by Cap. | +0.20% | -0.45% | +28.03% | +124.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.17M 33.15M 30.78M 28.39M 53.48M 3.64B 54.45M 364M 143M 1.81B 143M 140M 6.09B | 20.15M 17.51M 16.26M 14.99M 28.24M 1.92B 28.75M 192M 75.35M 956M 75.68M 74.02M 3.21B |
| Net income | -66.94M -58.14M -53.99M -49.79M -93.79M -6.39B -95.49M -639M -250M -3.17B -251M -246M -10.67B | -88.26M -76.66M -71.19M -65.66M -124M -8.43B -126M -843M -330M -4.18B -331M -324M -14.07B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/07/26 | $2.340 | +0.86% | 2,464,426 |
| 29/07/26 | $2.320 | -0.85% | 2,476,278 |
| 28/07/26 | $2.340 | +4.93% | 2,680,219 |
| 27/07/26 | $2.230 | -2.62% | 2,957,356 |
| 24/07/26 | $2.290 | -0.43% | 1,681,849 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LXRX Stock
Select your edition
All financial news and data tailored to specific country editions
